检索结果 - Toshner, Mark
- Showing 1 - 20 results of 59
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Rising COVID-19 related acute pulmonary emboli but falling national chronic thromboembolic pulmonary hypertension referrals from a large national dataset 由 Newman, Joseph, Boubriak, Iryna, Jenkins, David, Ng, Choo, Ruggiero, Alessandro, Screaton, Nicholas, Cannon, John, Toshner, Mark
出版 2021Text -
10
-
11
-
12
-
13
Modulation of endothelin receptors in the failing right ventricle of the heart and vasculature of the lung in human pulmonary arterial hypertension 由 Kuc, Rhoda E., Carlebur, Myrna, Maguire, Janet J., Yang, Peiran, Long, Lu, Toshner, Mark, Morrell, Nicholas W., Davenport, Anthony P.
出版 2014Text -
14
-
15
-
16
-
17
-
18
Clinical trial protocol for TRANSFORM-UK: A therapeutic open-label study of tocilizumab in the treatment of pulmonary arterial hypertension 由 Hernández-Sánchez, Jules, Harlow, Louise, Church, Colin, Gaine, Sean, Knightbridge, Emily, Bunclark, Kate, Gor, Dee, Bedding, Alun, Morrell, Nicholas, Corris, Paul, Toshner, Mark
出版 2017Text -
19
Log-transformation improves the prognostic value of serial NT-proBNP levels in apparently stable pulmonary arterial hypertension 由 Soon, Elaine, Doughty, Natalie J., Treacy, Carmen M., Ross, Robert M., Toshner, Mark, Upton, Paul D., Sheares, Karen, Morrell, Nicholas W., Pepke-Zaba, Joanna
出版 2011Text -
20
A minimal clinically important difference measured by the Cambridge Pulmonary Hypertension Outcome Review for patients with idiopathic pulmonary arterial hypertension 由 Bunclark, Katherine, Doughty, Natalie, Michael, Alice, Abraham, Nisha, Ali, Samantha, Cannon, John E, Sheares, Karen, Speed, Nicola, Taboada, Dolores, Toshner, Mark, Pepke-Zaba, Joanna
出版 2021Text